Entity Name: | Conjupro Biotherapeutics Inc. |
Jurisdiction: | Connecticut |
Legal type: | Stock |
Citizenship: | Foreign |
Status: | Active |
Sub status: | Annual report due |
Date Formed: | 16 Dec 2021 (Companies founded in December 2021) |
Business ALEI: | 2403672 |
Annual report due: | 16 Dec 2024 |
NAICS code: | 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
Business address: | 302 Carnegie Ctr, Princeton, NJ, 08540, United States |
Mailing address: | 302 Carnegie Ctr, 100, Princeton, NJ, United States, 08540 |
Place of Formation: | DELAWARE |
E-Mail: | jessica.wang@cspcus.com |
Name | Role | Business address | Residence address |
---|---|---|---|
Qingxi Wang | Officer | 302 Carnegie Ctr, 100, Princeton, NJ, 08540, United States | 302 Carnegie Ctr, 100, Princeton, NJ, 08540, United States |
Name | Role |
---|---|
Conjupro Biotherapeutics Inc. | Agent |
Filing number | Filing date | Effective date | Filing category | Filing type | Report year |
---|---|---|---|---|---|
BF-0012379175 | 2023-11-20 | No data | Annual Report | Annual Report | No data |
BF-0010409376 | 2022-11-18 | No data | Annual Report | Annual Report | 2022 |
BF-0010167213 | 2021-12-16 | No data | Business Registration | Certificate of Authority | No data |
Date of last update: 11 Nov 2024
Sources: Connecticut's Official State Website